Global Cardiac Biomarkers Market Size & Outlook, 2026-2033
Global cardiac biomarkers market, 2021-2033 (US$M)
Related Markets
Global cardiac biomarkers market highlights
- The global cardiac biomarkers market generated a revenue of USD 20,811.2 million in 2025 and is expected to reach USD 49,312.4 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 11.5% by 2033.
- In terms of segment, troponin accounted for a revenue of USD 8,357.8 million in 2025.
- Troponin is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 20,811.2 million |
| Market revenue in 2033 | USD 49,312.4 million |
| Growth rate | 11.5% (CAGR from 2026 to 2033) |
| Largest segment | Troponin |
| Fastest growing segment | Troponin |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK-MB, Myoglobin, Troponin, BNP and NT-proBNP |
Other key industry trends
- In terms of revenue, the North America accounted for 43.3% of the global cardiac biomarkers market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 3,282.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cardiac Biomarkers Market Scope
Cardiac Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Life Diagnostics | View profile | 1-10 | West Chester, Pennsylvania, United States, North America | http://lifediagnostics.com |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | http://www.creative-diagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global cardiac biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac biomarkers market will help companies and investors design strategic landscapes.
Troponin was the largest segment with a revenue share of 40.16% in 2025. Horizon Databook has segmented the Global cardiac biomarkers market based on ck-mb, myoglobin, troponin, bnp and nt-probnp covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2021-2033)
- Myoglobin
- CK-MB
- Troponin
- BNP and NT-proBNP
- Others
- Global Cardiac Biomarkers Application Outlook (Revenue, USD Million, 2021-2033)
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
- Others
- Global Cardiac Biomarkers End Use Outlook (Revenue, USD Million, 2021-2033)
- Point of Care Testing
- Laboratory Testing
Reasons to subscribe to Global cardiac biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global cardiac biomarkers market databook
-
Our clientele includes a mix of cardiac biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global cardiac biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global cardiac biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global cardiac biomarker market size, by regions, 2021-2033 (US$M)
Top 10 countries: Cardiac biomarker market size, 2025 (US$M)
Global cardiac biomarker market share, by type, 2025 & 2033 (%, US$M)
Cardiac biomarkers market: Opportunity assessment by country
Global cardiac biomarkers market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
